Etiological Agents of Health-care associated Surgical Site Infections by Rita Treimane et al.
BIO
Automation
Bioautomation, 2007, 6, 49 – 53   ISSN 1312 – 451X 
 
  49
Etiological Agents of Health-care associated Surgical 
Site Infections 
 
Aija Žileviča
1, Rita Treimane
2, Uldis Viesturs
2,3* 
 
1 University of Latvia, Faculty of Medicine,  
1a Šarlotes Str., LV-1001 Riga, Latvia 
E-mail: aija.zilevica@tos.lv 
http://www.lza.lv/scientists/zilevica.htm 
 
2 Institute of Microbiology and Biotechnology, University of Latvia,  
4 Kronvalda blvd., LV-1586, Riga, Latvia 
E-mail: lumbi@lanet.lv  
 
3 Latvian State Institute of Wood Chemistry,  
27 Dzerbenes Str., LV-1006, Riga, Latvia 
Phone: 371 7 553063, 371 7 034884, Fax: 371 7 550635 
E-mail: koks@edi.lv 
http://www.lza.lv/scientists/viestursu.htm 
 
* Corresponding author 
 
Received: February 2, 2007  Accepted: Mart 16, 2007 
  
  Published: Mart 27, 2007 
 
Abstract:  Surgical site infection is the second most common nosocomial (health-care 
associated) infection among hospitalized patients and is a significant public health problem 
worldwide. Infections caused by multiresistant microorganisms are of special concern 
because of difficulties to treat them. From 1484 clinical samples, we isolated 1117 cultures 
of different gram-positive and gram-negative microorganisms. The leading agents were 
S. aureus and coagulase-negative Staphylococci. Methicillin resistance among S. aureus was 
low, while it exceeded 50% in CoNS. From gram-negative bacteria, representatives of the 
family Enterobacteraceae and non-fermenting rods were isolated in similar amounts. ESBL 
producers among E. coli and K. pneumoniae were not registered.  
 
Keywords:  Nosocomial infections, Gram-positive and gram-negative microorganisms, 
Methicillin resistance. 
 
Introduction 
Health-care associated infections (HCAI) or nosocomial infections represent an important 
public health problem worldwide and are of increasing interest not only for medical staff, but 
also for the general public and politicians. HSAI are a major source of morbidity and 
mortality of patients in acute-care hospitals. The infection rate varies from 5-25% in different 
countries and poses medical as well as financial and psychological problems [1, 14, 15, 17]. 
  
Surgical site infection (SSI) is the second most common (after urinary tract infections) 
nosocomial infection among hospitalized patients. The reported SSI rates vary from 2.8 to 
20%, depending on the hospital characteristics, patient characteristics and surgical procedures. 
Even antibiotic prophylaxis not always reduces the occurrence of SSI [2, 5, 7, 10]. 
 
Nosocomial infections are caused by a great variety of different gram-positive and gram-
negative microorganisms, mainly opportunists. One of their most prominent features is 
polyresistance to antimicrobials. So, nosocomial infections, particularly those caused by BIO
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multiresistant microorganisms, which are difficult to treat, are one of the main causes of 
concern for modern medicine.  
 
The aim of the present study was to assess the frequency and distribution of health-care 
associated surgical site infections caused by different gram-positive and gram-negative 
microorganisms in a surgical hospital with a special reference to multiresistant 
microorganisms.  
 
Materials and methods 
The study was carried out during 2005-2006 at the Hospital of Traumatology and 
Orthopaedics, Riga, Latvia. Samples from patients with hospital-acquired purulent surgical 
site infections were examined. Most of the cultures were isolated from wounds, skin, 
abscesses, indwelling artificial devices and joints. Cultures of the samples were performed by 
conventional methods. The BBL Crystal gram-positive and gram-negative ID System 
(Becton, Dickinson) was used for identification of isolates at the species level. The resistance 
to a panel of antimicrobials was tested by the disk diffusion method according to CLSI 
standards. Methicillin resistance in Staphylococci was confirmed by the agar screening 
method on agar plates supplemented with 6 mg/ml oxacillin. The presence of the mecA gene 
was tested by the PCR technique. As complementary tests, the E-test (AB Biodisk) and Slidex 
MRSA (Bio Merieux, France) reaction, detecting the production of PBP2a, encoded by the 
mecA gene, were used [16].  
 
Results and discussion 
From 1484 clinical samples, 1117 cultures were isolated (556 and 561 during the years 2005 
and 2006, respectively).  
 
The leading nosocomial agents were gram-positive microorganisms (Table 1). 
 
Table 1. Ratio of gram-positive and gram-negative flora isolated from SSI in 2005-2006 
Years  Microorganisms 
2005 2006 
Gram-positive flora  388 cultures – 79.67%  429 cultures – 76.47% 
Gram-negative flora  99 cultures – 20.33%  132 cultures – 23.53% 
 
The results demonstrate that the situation was rather stable during the two years. 
 
The analysis of gram-positive microorganisms revealed the leading role of Staphylococci, 
both coagulase-positive and coagulase-negative Staphylococci (CoNS) (Table 2).  
 
Table 2. Isolated gram-positive microorganisms 
Years 
Microorganisms  2005 
(abs., % of gram-positive) 
2006 
(abs., % of gram-positive) 
S. aureus  220 cultures – 56.7%  202 cultures - 47.08% 
CoNS  141 cultures – 36.34%  155 cultures - 36.3% 
Others  27 cultures – 6.96%  72 cultures - 16.62% 
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From 220 cultures of S. aureus, isolated during 2005, 8 occurred to be methicillin-resistant, 
while from 2002 cultures isolated in the year 2006, 12 were methicillin-resistant. 
 
It is well known that S. aureus is a major cause of hospital-acquired infections worldwide, 
while, since the late 1970s, methicillin-resistant S. aureus, has spread. Due to its 
polyresistance, infections caused by MRSA lead to substantial morbidity and mortality as 
well as high healthcare costs [3, 11]. 
 
No outbreaks of the MRSA infection in our hospital were registered. Bloodstream infection, 
caused by MRSA, was documented in 1 patent in 2006.  
 
A different situation was observed in coagulase-negative Staphylococci. The average 
methicillin resistance was more than 50%, especially high in S. haemolyticus, S. hominis, S. 
Saprophyticus (Table 3).  
 
Table 3. Methicillin resistance in CoNS, isolated in 2005 
Microorganisms  Number of cultures  Methicillin-
resistant 
Methicillin-
sensitive 
S. epidermidis  79 31  48 
S. haemolyticus  20 18  2 
S. hominis  17 15  2 
S. capitis  3 1  2 
S. simulans  5 2  3 
S. intermedius  1 0  1 
S. vitulinus  2 0  2 
S. saprophyticus  8 7  1 
S. cohnii  3 2  1 
S. felis  1 0  1 
S. saccharolyticus  1 1  0 
S. warneri  1 1  0 
 
In the year 2006, the situation was similar. 
 
The average incidence rate of methicillin resistance among CoNS in the years 2005 and 2006 
was 53.9% and 51.23%, respectively. 
 
Other gram-positive organisms were isolated rarely. The following species were isolated: 
Enterococcus faecalis (2.9%), Enterococcus faecium (2.6%), Streptococcus agalactiae 
(1.8%), Corynebacterium spp. (0.7%), Lactococcus spp. (0.7%), Micrococcus spp. (1.1%), 
etc. 
 
Vancomycin-resistant Enterococci were not registered. 
 
Over the past 25 years, gram-positive infections have become a serious clinical problem 
because of an unrelenting increase in antimicrobial resistance. The emergence of pathogens 
such as methicillin-resistant Staphylococci and vancomycin-resistant Enterococci has had a 
significant impact on the treatment of diseases and created a substantial economic burden.  
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S. aureus causes a wide spectrum of infections – skin/soft tissue infections, bone/joint 
infections, prosthetic valve and other infections [8, 9, 12].  
 
Coagulase-negative Staphylococci, particularly S. epidermidis, the most frequently isolated 
member of the CoNS group, are involved in catheter-related and bloodstream infections, 
infections of the ear, nose, throat, eye, etc. [13, 18]. 
 
From gram-negative microorganisms causing SSI, mainly non-fermenting rods and 
representatives of the family Enterobacteriaceae were isolated (Table 4).  
 
Table 4. Isolated gram-negative microorganisms 
Years 
Microorganisms  2005 
(abs., % of gram-negative) 
2006 
(abs., % of gram-negative) 
Family 
Enterobacteriaceae  51 cultures – 52.52%  54 cultures - 40.9% 
Non-fermenting 
microorganisms  48 cultures – 48.48%  78 cultures – 59.1% 
 
From the family Enterobacteriaceae, the most often isolated were Enterobacter spp. (16.2%), 
followed by Klebsiella spp. (10.1%), E. coli (8.1%) and Serratia, Morganella, Citobacter spp. 
 
Extended spectrum beta-lactamases (ESBL) producers among E. coli and Klebsiella 
pneumoniae were not registered.  
 
During 2 years, there had been a tendency in increasing of isolates belonging to non-
fermenting rods in our hospital – from 48.48% in the year 2005 to 59.1% in 2006. The leading 
agents were Pseudomonas spp. and Acinetobacter baumannii. Their ratio changed 
insignificantly – 52.9% and 41.2% in the year 2005, and 48.7% and 43.5% in the year 2006, 
respectively. 
 
Changes in the epidemiology of non-fermenting gram-negative rods, especially A. baumannii, 
have been witnessed in recent years in many countries. The infections caused by these 
microorganisms have become increasingly common among critically ill patients in intensive 
care units (ICU) [4, 6]. 
 
In our hospital, we also isolated A. baumannii mainly from patients in ICU. 
 
Conclusions 
Surgical site infections were caused mainly by gram-positive microorganisms – the leading 
agents were Staphylococcus aureus, followed by coagulase-negative Staphylococci. 
Methicillin resistance among S. aureus was low, and outbreaks were not registered. 
Methicillin resistance among CoNS was more than 50%. 
 
Gram-negative agents of SSI, representatives of the family Enterobacteriaceae  and  non-
fermenting genera Pseudomonas and Acinetobacter were registered in similar amounts.  
 
ESBL producers among E. coli and K. pneumoniae were not documented. 
 BIO
Automation
Bioautomation, 2007, 6, 49 – 53   ISSN 1312 – 451X 
 
  53
Acknowledgements 
This study was supported by the Project No. 04. 1034 of the Latvian Council of Science. 
 
 
References 
1.  Bouza E., P. Munoz (2005). Introduction: Infections Caused by Emerging Resistant 
Pathogens, Clin. Microbiol. Infect., 11 (4), 1. 
2.  Bratzler D. W., P. M. Houck (2004). Surgical Infection Prevention Guidelines, Clin. 
Infect. Dis., 38, 1706-1715. 
3.  Cunha B. A. (2005). Methicillin-resistant Staphylococcus aureus: Clinical Manifestations 
and Antimicrobial Therapy, Clin. Microbiol. Infect., 11 (4), 33-42. 
4.  Da Silva G., L. Dijkshoorn, T. Van der Reijden, B. Van Strijen, A. Duarte (2007). 
Identification of Wide-spread, Closely Related Acinerobacter baumannii Isolates in 
Portugal as a Subgroup of European Clone II, Clin. Microbiol. Infect., 13 (2), 190-195. 
5.  Emmanuel J. C. (2004). Surgical Techniques. Prophylaxis, In: Surgical Care at the 
District Hospital, Wtto, Geneva, 4 (10), 11. 
6.  Falagas M. E., E. A. Karveli (2007). The Changing Global Epidemiology of 
Acinetobacter baumannii Infections: A Development with Major Public Health Infections, 
Clin. Microbiol. Infect., 13 (2), 117-119. 
7.  Fehr J., C. Hatz, I. Soka, T. Kibatala, H. Urassa, M. Battegay, Z. Jeffrey, T. Smith, R.  
Frei, A. Widmer (2006). Antimicrobial Prophylaxis to Prevent Surgical Site Infections in 
a Rural Sub-Saharan Hospital, Clin. Microbiol. Infect., 12 (12), 1224-1227. 
8.  Finch R. (2006). Gram-positive Infections: Lessons Learnt and Novel Solutions, Clin. 
Microbiol. Infect., 12 (8), 3-8. 
9.  Humphreys H., E. T. M. Smyth (2006). Prevalence Surveys of Health-care Associated 
Infections: What Do They Tell Us, if Anything, Clin. Microbiol. Infect., 12 (1), 2-4. 
10. Ligan-Garcia M., J. Garcia-Caballero, A. Vegas (1997). Risk Factors for Surgical-wound 
Infection in General Surgery: A Prospective Study, Infection Control and Hospital 
Epidemiology, 18 (5), 310-315. 
11. Schito G. C. (2006). The Importance of the Development of Antibiotic Resistance in 
Staphylococcus aureus, Clin. Microbiol. Infect., 12 (1), 3-8.  
12. Tattevin P., C. Arvieux, C. Michelet (2006). What is the Place of Teicoplanin and 
Linezolid in the Treatment of Prosthetic Joint Infections, Clin. Microbiol. Infect., 12 (12), 
1241-1242. 
13. Vuong C., M. Otto (2002). Staphylococcus epidermidis Infections, Microbes and 
Infection, 4, 481-489. 
14. Žileviča A. (2005). Hospital-acquired and Community-acquired Uropathogens; Modelling 
of Infection, Bioautomation, 3, 63-67. 
15. Zilevica A., R. Paberza (2006). Etiological Agents of Nosocomial Urinary Tract 
Infections, Proc. of LU, 694, 136-144. 
16. Zilevica A., T. Tracevska (2006). Staphylococcal Infections in a Surgical Hospital, Proc. 
of LU, 694, 145-153. 
17. Zilevica A., U. Viesturs (2005). Modelling of the Etiological Structure of Urinary Tract 
Infections, – Proceedings of the International Symposium Bioprocess Systems 2005 – 
BioPS’05, 25-26 October, Sofia, Bulgaria, III.1-III.6. 
18. Weinstein R. A. (2001). Device-related Infections, Helthcare Epidemiology, 33, 1386. 
 